Developer’s conference for the world’s first approval of “Photoimmunetherapy”, a new medicine cure for cancer.
The medicine for cancer that combines a reaction with light with chemicals was approved last week for the first time around the world, a new treatment medicine that after prescribed to patients fights the cancer cell hit by light.
The reseaecher who developed this medicine held a press conference and showed hope, “i think it would be good if we could make one more option as a cancer cure.”
Head researcher Hisataka Kobayashi, affiliated the National Institute of Health in the US, developed a treatment for cancer that combined a chemical which reacts to light for a medicine used and antibody made to target the cancer, and has been recognized within Japan last week, for the first time world wide, as another treatment for cancer in the head.
The medicine, having been prescribed to patients as an IV, applies a near infrared radiated laser light from outside of the body, activating change and destroying cancer cells, a plan being called, “photoimmunotherapy.”
Head researcher Kobayashi states that because researching this treatment took a few decades, he “is happy that it is recognized in Japan, for if it doesn’t reach patients, then there is no meaning.
I think if one more cancer treatment option became available, then that’s good.”
In addition, Chairman Mikitani shows hope and said, “I think that this will become a possibility to combine with another chemotherapy.
Ii want patients to quickly receive this as soon as possible.”
Todaii Japanese is a website for learning and reading Japanese news integrating various features such as dictionary, practice, testing, ...
https://todaiinews.com
todai.easylife@gmail.com
(+84) 865 924 966
315 Truong Chinh, Khuong Mai, Thanh Xuan, Hanoi
Home
Video
JLPT Test
Dictionary
Lesson
Topic
